BRAINSTORM CELL THERAPEUTICS INC. Quarterly Return On Assets in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Brainstorm Cell Therapeutics Inc. quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q3 2024.
  • Brainstorm Cell Therapeutics Inc. Return On Assets for the quarter ending September 30, 2024 was -373 %, a 55.5% decline year-over-year.
  • Brainstorm Cell Therapeutics Inc. annual Return On Assets for 2023 was -293 %, a 100% decline from 2022.
  • Brainstorm Cell Therapeutics Inc. annual Return On Assets for 2022 was -146 %, a 131% decline from 2021.
  • Brainstorm Cell Therapeutics Inc. annual Return On Assets for 2021 was -63.3 %, a 39.7% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -373 -133 -55.5% Jul 1, 2024 Sep 30, 2024
Q2 2024 -269 -17.4 -6.88% Apr 1, 2024 Jun 30, 2024
Q1 2024 -327 -130 -65.6% Jan 1, 2024 Mar 31, 2024
Q4 2023 -293 -146 -100% Oct 1, 2023 Dec 31, 2023
Q3 2023 -240 -123 -106% Jul 1, 2023 Sep 30, 2023
Q2 2023 -252 -164 -186% Apr 1, 2023 Jun 30, 2023
Q1 2023 -198 -127 -181% Jan 1, 2023 Mar 31, 2023
Q4 2022 -146 -82.9 -131% Oct 1, 2022 Dec 31, 2022
Q3 2022 -117 -48.5 -71.2% Jul 1, 2022 Sep 30, 2022
Q2 2022 -88.2 -21.2 -31.7% Apr 1, 2022 Jun 30, 2022
Q1 2022 -70.3 +9.78 +12.2% Jan 1, 2022 Mar 31, 2022
Q4 2021 -63.3 +41.7 +39.7% Oct 1, 2021 Dec 31, 2021
Q3 2021 -68.1 +76.6 +52.9% Jul 1, 2021 Sep 30, 2021
Q2 2021 -66.9 +156 +70% Apr 1, 2021 Jun 30, 2021
Q1 2021 -80 +175 +68.6% Jan 1, 2021 Mar 31, 2021
Q4 2020 -105 +160 +60.4% Oct 1, 2020 Dec 31, 2020
Q3 2020 -145 +66 +31.3% Jul 1, 2020 Sep 30, 2020
Q2 2020 -223 -61.6 -38.1% Apr 1, 2020 Jun 30, 2020
Q1 2020 -255 -140 -121% Jan 1, 2020 Mar 31, 2020
Q4 2019 -265 -165 -164% Oct 1, 2019 Dec 31, 2019
Q3 2019 -211 -151 -254% Jul 1, 2019 Sep 30, 2019
Q2 2019 -162 -105 -186% Apr 1, 2019 Jun 30, 2019
Q1 2019 -115 -60.9 -112% Jan 1, 2019 Mar 31, 2019
Q4 2018 -101 -50.9 -102% Oct 1, 2018 Dec 31, 2018
Q3 2018 -59.6 +0.21 +0.35% Jul 1, 2018 Sep 30, 2018
Q2 2018 -56.5 -5.36 -10.5% Apr 1, 2018 Jun 30, 2018
Q1 2018 -54.4 -9.85 -22.1% Jan 1, 2018 Mar 31, 2018
Q4 2017 -49.8 -9.49 -23.6% Oct 1, 2017 Dec 31, 2017
Q3 2017 -59.8 -18.6 -45.2% Jul 1, 2017 Sep 30, 2017
Q2 2017 -51.2 -7.97 -18.5% Apr 1, 2017 Jun 30, 2017
Q1 2017 -44.6 +1.64 +3.55% Jan 1, 2017 Mar 31, 2017
Q4 2016 -40.3 +3.13 +7.21% Oct 1, 2016 Dec 31, 2016
Q3 2016 -41.2 +14.2 +25.6% Jul 1, 2016 Sep 30, 2016
Q2 2016 -43.2 +17.1 +28.3% Apr 1, 2016 Jun 30, 2016
Q1 2016 -46.2 +20.5 +30.7% Jan 1, 2016 Mar 31, 2016
Q4 2015 -43.4 +53.8 +55.4% Oct 1, 2015 Dec 31, 2015
Q3 2015 -55.4 +38.8 +41.2% Jul 1, 2015 Sep 30, 2015
Q2 2015 -60.3 +32.2 +34.8% Apr 1, 2015 Jun 30, 2015
Q1 2015 -66.7 +58.6 +46.8% Jan 1, 2015 Mar 31, 2015
Q4 2014 -97.3 +3.32 +3.3% Oct 1, 2014 Dec 31, 2014
Q3 2014 -94.2 -8.54 -9.97% Jul 1, 2014 Sep 30, 2014
Q2 2014 -92.5 -3.27 -3.67% Apr 1, 2014 Jun 30, 2014
Q1 2014 -125 -41.9 -50.3% Jan 1, 2014 Mar 31, 2014
Q4 2013 -101 -8.85 -9.65% Oct 1, 2013 Dec 31, 2013
Q3 2013 -85.7 +120 +58.4% Jul 1, 2013 Sep 30, 2013
Q2 2013 -89.2 +149 +62.6% Apr 1, 2013 Jun 30, 2013
Q1 2013 -83.4 +54.5 +39.5% Jan 1, 2013 Mar 31, 2013
Q4 2012 -91.7 Oct 1, 2012 Dec 31, 2012
Q3 2012 -206 Jul 1, 2012 Sep 30, 2012
Q2 2012 -238 Apr 1, 2012 Jun 30, 2012
Q1 2012 -138 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.